These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 10192393)

  • 1. A common human skin tumour is caused by activating mutations in beta-catenin.
    Chan EF; Gat U; McNiff JM; Fuchs E
    Nat Genet; 1999 Apr; 21(4):410-3. PubMed ID: 10192393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin.
    Lazar AJ; Calonje E; Grayson W; Dei Tos AP; Mihm MC; Redston M; McKee PH
    J Cutan Pathol; 2005 Feb; 32(2):148-57. PubMed ID: 15606674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
    Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
    Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-catenin mutations in a common skin cancer: pilomatricoma].
    Durand M; Molès JP
    Bull Cancer; 1999 Sep; 86(9):725-6. PubMed ID: 10519964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas.
    Xia J; Urabe K; Moroi Y; Koga T; Duan H; Li Y; Furue M
    J Dermatol Sci; 2006 Jan; 41(1):67-75. PubMed ID: 16378715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin.
    Fujita M; Furukawa Y; Nagasawa Y; Ogawa M; Nakamura Y
    Cancer Res; 2000 Dec; 60(23):6683-7. PubMed ID: 11118053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential formation of beta-catenin/lymphoid enhancer factor-1 DNA binding complex induced by nitric oxide in mouse colonic epithelial cells differing in adenomatous polyposis coli (Apc) genotype.
    Mei JM; Hord NG; Winterstein DF; Donald SP; Phang JM
    Cancer Res; 2000 Jul; 60(13):3379-83. PubMed ID: 10910042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
    Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
    Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
    Wu R; Zhai Y; Fearon ER; Cho KR
    Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
    Hämmerlein A; Weiske J; Huber O
    Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
    Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
    Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.
    Sparks AB; Morin PJ; Vogelstein B; Kinzler KW
    Cancer Res; 1998 Mar; 58(6):1130-4. PubMed ID: 9515795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
    Jung HC; Kim K
    Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
    Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
    Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hot spots in beta-catenin for interactions with LEF-1, conductin and APC.
    von Kries JP; Winbeck G; Asbrand C; Schwarz-Romond T; Sochnikova N; Dell'Oro A; Behrens J; Birchmeier W
    Nat Struct Biol; 2000 Sep; 7(9):800-7. PubMed ID: 10966653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare activation of the TCF/beta-catenin pathway in ovarian cancer.
    Furlong MT; Morin PJ
    Gynecol Oncol; 2000 Apr; 77(1):97-104. PubMed ID: 10739697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
    Gustavson MD; Crawford HC; Fingleton B; Matrisian LM
    Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of cyclooxygenase-2 and nuclear beta-catenin are related to mutations in the APC gene in human colorectal cancer.
    Dimberg J; Hugander A; Sirsjö A; Söderkvist P
    Anticancer Res; 2001; 21(2A):911-5. PubMed ID: 11396184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
    Bhatia N; Spiegelman VS
    Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation.
    Daniels DL; Weis WI
    Nat Struct Mol Biol; 2005 Apr; 12(4):364-71. PubMed ID: 15768032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.